NCT03727399View on ClinicalTrials.gov

Identification of Allergen-reactive Antibodies in the Blood of Pollen Allergic Patients

Enrolling by invitationOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Pollen Allergy
Interventions
OTHER

blood withdrawal

Blood withdrawal

Trial Locations (1)

8006

Immunologie Zentrum Zürich, Zurich

Sponsors

Lead Sponsor

Mabylon AG
All Listed Sponsors
lead

Mabylon AG

INDUSTRY

NCT03727399 - Identification of Allergen-reactive Antibodies in the Blood of Pollen Allergic Patients | Biotech Hunter | Biotech Hunter